NCT01448070View on ClinicalTrials.gov

Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

October 15, 2002

Primary Completion Date

December 20, 2002

Study Completion Date

December 20, 2002

Conditions

DiabetesHealthy

Interventions

DRUG

human insulin

Single dose of 0.2 IU/kg, administered subcutaneously (under the skin)

Trial Locations (1)

M15 6SH

Novo Nordisk Investigational Site, Manchester

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY